Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival

Last updated: June 6, 2024
Sponsor: Peking University First Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Dementia

Cancer Treatment

Treatment

Target temperature management

Routine thermal management

Clinical Study ID

NCT06256354
2024-185
  • Ages > 65
  • All Genders

Study Summary

Intraoperative hypothermia is common in patients having major surgery and the compliance with intraoperative temperature monitoring and management remains poor. Studies suggest that intraoperative hypothermia is an important risk factor of postoperative delirium, which is associated with worse early and long-term outcomes. Furthermore, perioperative hypothermia increases stress responses and provokes immune suppression, which might promote cancer recurrence and metastasis. In a recent trial, targeted temperature management reduced intraoperative hypothermia and emergence delirium. There was also a trend of reduced postoperative delirium, although not statistically significant. This trial is designed to test the hypothesis that intraoperative targeted temperature management may reduce postoperative delirium and improves progression-free survival in older patients recovering from major cancer surgery.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age ≥65 years.

  2. Planned potentially curative initial cancer surgery with an expected duration of 2hours or longer under general anesthesia.

Exclusion

Exclusion Criteria:

  1. Preoperative fever (tympanic temperature ≥38℃).

  2. Known or suspected preoperative infection.

  3. Previous history of schizophrenia, epilepsy, Parkinson disease, myasthenia gravis,or delirium.

  4. Unable to communicate due to severe dementia, language barrier, or coma.

  5. Critically ill (Left ventricular ejection fraction <30%, Child-Pugh grades C,requirement of renal replacement therapy, American Society of Anesthesiologistsphysical status>IV, or expected survival <24 hours).

  6. Scheduled surgery for breast cancer, intracranial tumors, or rare cancers.

  7. Planned to undergo therapeutic hypothermia.

  8. Body mass index >30 kg/m2.

  9. Have participated in this study previously.

  10. Any other conditions that are considered unsuitable for study participation.

Study Design

Total Participants: 3992
Treatment Group(s): 2
Primary Treatment: Target temperature management
Phase:
Study Start date:
May 29, 2024
Estimated Completion Date:
January 31, 2030

Study Description

Perioperative hypothermia results from anesthetic-impaired thermoregulatory responses combined with cool operating rooms and exposed body cavities. Core temperatures <35.5°C increases perioperative blood loss, delays post anesthetic recovery, and increases surgical wound infections.

Despite guideline recommendations, compliance with intraoperative temperature monitoring and management remains poor. In a national survey published in 2017, intraoperative hypothermia (core temperature <36.0°C) occurred in 44% of patients having elective surgery with general anesthesia. According to a survey of anesthesiologists in six Asia-Pacific countries (Singapore, Malaysia, Philippines, Thailand, India, and South Korea), only 67% of respondents measured temperature intraoperatively during general anesthesia, and only 44% report intraoperative active warming and warming was ineffective in more than half of their patients. Perioperative hypothermia thus remains common.

The 5,056-patient PROTECT trial showed that myocardial injury, surgical site infections, and blood loss were similar in patients randomized to intraoperative core temperatures of 35.5 or 37°C. However, there are other important complications that may be caused by intraoperative hypothermia including delirium, cancer recurrence, shivering, and thermal discomfort.

Perioperative neurocognitive disorders (NCDs), especially postoperative delirium and postoperative cognitive dysfunction (POCD), are significant challenges to older patients scheduled for surgery. Delirium is a syndrome of acutely occurring and fluctuating changes in attention, level of consciousness, and cognitive function. Postoperative cognitive dysfunction refers to cognitive decline (including the ability of study, memory, action, and judgement) detected from 30 days to 12 months after surgery.

In patients aged 60 years or above, the incidence of postoperative delirium is about 12-24%. The incidence of POCD is about 7-12% at 3-month follow-up and is associated with delirium, although the relationship is probably not causal. Delirium and POCD are associated with worse perioperative outcomes including prolonged hospitalization, increased complications, and high mortality, and worse long-term outcomes including shortened overall survival, as well as increased dementia and lowered life quality.

Postoperative delirium and POCD are multifactorial. Predisposing factors include advanced age, lower educational level, cognitive impairment, comorbidities (e.g., cerebrovascular disease, diabetes, and kidney disease), alcohol abuse, and malnutrition. Precipitating factors include deep anesthesia, opioid use, benzodiazepines, intraoperative blood loss/blood transfusion, and severe pain. Hypothermia may also increase the risk of delirium.

Hypothermia provokes both autonomic and behavioral protective responses. The first autonomic response is arterio-venous shunt constriction. Thermoregulatory vasoconstriction occurs many times a day in a typical hospital environment. It is highly effective, but does not usually disturb people and is generally considered to be of little consequence. Shivering is the other primary autonomic thermoregulatory defense against cold and has a triggering threshold about 1°C below the core temperature that triggers vasoconstriction. Unlike vasoconstriction, shivering is uncomfortable for patients. Furthermore, it is accompanied by a tripling of catecholamine concentrations, hypertension, and tachycardia. Behavioral thermoregulatory defenses are mediated by thermal comfort, and provoke voluntary defensive measures such as putting on a sweater, open windows, etc. Behavioral defenses include air conditioning and building shelters and are thus far stronger than autonomic responses. Thermal comfort matters to patients and is thus worth evaluating.

Despite advances in surgery and oncology, postoperative survival decreases about 10% per year, mainly due to cancer recurrence. The development of cancer recurrence mainly depends on the balance between the invasive ability of residual cancer cells and the anti-cancer immune function. Perioperative hypothermia increases stress responses and provokes immune suppression.

The investigators therefore propose to determine whether intraoperative targeted temperature management decreases the incidence of delirium, improves thermal comfort, reduces postoperative shivering, and improves long-term survival in older patients recovering from major cancer surgery. Specifically, the investigators will test the primary short-term hypothesis that perioperative normothermia (core temperature near 36.8°C) reduces delirium over the initial 4 postoperative days. Secondary short-term hypotheses are that perioperative normothermia improves thermal comfort, reduces shivering, and reduces delayed neurocognitive recovery. The primary long-term hypothesis is that perioperative normothermia improves progression-free survival.

Connect with a study center

  • The Pepple's Hospital of Chizhou

    Chizhou, Anhui 247099
    China

    Site Not Available

  • Dongzhimen Hospital Beijing University of Chinese Medicine

    Beijing, Beijing 100007
    China

    Site Not Available

  • Guang'anmen Hospital China Academy of Chinese Medical Sciences

    Beijing, Beijing 100055
    China

    Site Not Available

  • Peking Union Medical College Hospital

    Beijing, Beijing 100730
    China

    Site Not Available

  • Peking University First Hospital

    Beijing, Beijing 100034
    China

    Active - Recruiting

  • Xiyuan Hospital of CACMS(China Academy of Chinese Medical Sciences

    Beijing, Beijing 100091
    China

    Site Not Available

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing
    China

    Site Not Available

  • Peking University Shenzhen Hospital

    Shenzhen, Guangdong 518034
    China

    Site Not Available

  • The Fourth Hospital of Hebei Medical University (Hebei Tumor Hospital)

    Shijia Zhuang, Hebei 050011
    China

    Site Not Available

  • Henan Provincial People's Hospital

    Zhengzhou, Henan 463599
    China

    Site Not Available

  • The First Affiliated Hospital Of Zhengzhou University

    Zhengzhou, Henan 450052
    China

    Site Not Available

  • Jiangyin People's Hospital

    Jiangyin, Jiangsu 214400
    China

    Site Not Available

  • Jiangsu Province Hospital

    Nanjing, Jiangsu 210029
    China

    Site Not Available

  • The People's Hospital of Wuxi

    Wuxi, Jiangsu 214023
    China

    Site Not Available

  • The First Affiliated Hospital Of Shandong First Medical University

    Jinan, Shandong 250013
    China

    Site Not Available

  • The Pepple's Hospital of Liaocheng

    Liaocheng, Shandong 252000
    China

    Site Not Available

  • Xijing Hospital, Fourth Military Medical University

    Xi'an, Shanxi 710032
    China

    Site Not Available

  • Sichuan Provincial People's Hospital

    Chendu, Sichuan 610072
    China

    Site Not Available

  • The First Affiliated Hospital of Chengdu Medical College

    Chendu, Sichuan 610500
    China

    Site Not Available

  • Chengdu Seventh People's Hospital

    Chengdu, Sichuan 610041
    China

    Site Not Available

  • Sichuan Cancer Hospital

    Chengdu, Sichuan 610042
    China

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.